No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors

被引:37
|
作者
Rietbergen, Michelle M. [1 ]
Braakhuis, Boudewijn J. M. [1 ]
Moukhtari, Nadia [1 ]
Bloemena, Elisabeth [2 ,3 ]
Brink, Arjen [1 ]
Sie, Daoud [3 ]
Ylstra, Bauke [3 ]
de Jong, Robert J. Baatenburg [4 ]
Snijders, Peter J. F. [3 ]
Brakenhoff, Ruud H. [1 ]
Leemans, C. Rene [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Acad Ctr Dent Amsterdam ACTA, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands
[4] Erasmus MC, Dept Otolaryngol Head & Neck Surg, Rotterdam, Netherlands
关键词
SQUAMOUS-CELL CARCINOMA; 2ND PRIMARY TUMORS; GENETICALLY ALTERED FIELDS; NECK-CANCER PATIENTS; CLINICAL-IMPLICATIONS; COPY NUMBER; ARRAY CGH; HEAD; CANCERIZATION; PREVALENCE;
D O I
10.1111/jop.12123
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinomas (OPSCCs) have a better prognosis than patients with HPV-negative OPSCCs. Important factors contributing to this better prognosis are relatively low numbers of local/regional recurrences (LRRs) and second primary tumors (SPTs) in patients with HPV-positive OPSCC. These low numbers may be explained in addition by the absence of a 'field cancerization' effect, which is a cause of LRRs and SPTs in patients with HPV-negative OPSCC. We aimed to detect a possible 'field effect' in patients with HPV-positive OPSCC. As HPV is involved in the early stage of carcinogenesis in OPSCCs, its presence is considered a reliable marker for the detection of such a field effect. Therefore, the presence of transcriptionally active HPV was analyzed in the mucosa surrounding HPV-positive OPSCCs. Methods: We included 20 patients who were surgically treated for an HPV-positive OPSCC in the period 2000-2006. Of each patient, the formalin-fixed paraffin-embedded tumor sample and all available resection margins were collected. In total, 97 resection margins were investigated with an average of five resection margins per tumor. All samples were analyzed for the presence of tumor and the presence of transcriptionally active HPV by HPV16-E6-mRNA detection. Results: All tumors were HPV16-E6-mRNA positive. HPV16-E6-mRNA could be detected in the resection margins that contained tumor (n = 6). All tumor-negative resection margins (n = 91) scored negative for HPV16-E6-mRNA. Conclusions: In conclusion, transcriptional active HPV could not be detected in the mucosa surrounding an HPV-positive OPSCC, which suggests the absence of field effect. This observation may explain the lower number of LRRs and SPTs in HPV-positive patients. © 2013 John Wiley & Sons A/S.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [41] Prospective assessment of multiple HPV-positive oropharyngeal squamous cell carcinomas
    Faden, Daniel L.
    O'Boyle, Connor J.
    Lin, Derrick T.
    Deschler, Daniel G.
    Emerick, Kevin S.
    Varvares, Mark A.
    Faquin, William C.
    Sadow, Peter M.
    Richmon, Jeremy D.
    ORAL ONCOLOGY, 2021, 117
  • [42] Circulating Tumor HPV DNA for Surveillance of HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Narrative Review
    Kuhs, Krystle A. Lang
    Brenner, J. Chad
    Holsinger, F. Chris
    Rettig, Eleni M.
    JAMA ONCOLOGY, 2023, 9 (12) : 1716 - 1724
  • [43] Prognostic value of inflammatory markers in HPV-positive and HPV-negative patients with oropharyngeal cancer (OPC)
    Mrochem-Kwarciak, Jolanta
    Wygoda, Andrzej
    Rutkowski, Tomasz
    Chmura, Aleksandra
    Deja, Regina
    Mazurek, Agnieszka
    Skladowski, Krzysztof
    ORAL ONCOLOGY, 2021, 118
  • [44] Primary Chemotherapy and Radiation as a Treatment Strategy for HPV-Positive Oropharyngeal Cancer
    Vivian Wai Yan Lui
    Jennifer Rubin Grandis
    Head and Neck Pathology, 2012, 6 (Suppl 1) : 91 - 97
  • [46] Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review
    Morand, Gregoire B.
    Diaconescu, Alina
    Ibrahim, Iman
    Lamarche, Genevieve
    Ruas, Juliana S.
    Dalfen, Jacqueline
    Hier, Michael P.
    Alaoui-Jamali, Moulay A.
    Maschietto, Mariana
    da Silva, Sabrina Daniela
    CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (03) : 407 - 416
  • [47] Novel de-escalation strategy for HPV-positive oropharyngeal cancer
    Yokota, Tomoya
    ANNALS OF ONCOLOGY, 2022, 33 : S422 - S422
  • [48] Radiotherapy versus Surgery in Early Stage HPV-positive Oropharyngeal Cancer
    Kim, D.
    Wu, H.
    Kim, J. H.
    Ahn, S.
    Chung, E.
    Eom, K.
    Jung, Y. H.
    Jeong, W.
    Kwon, T.
    Kim, S.
    Wee, C. W.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S819 - S819
  • [49] The association of smoking and outcomes in HPV-positive oropharyngeal cancer: A systematic review
    Chen, Stephanie Y.
    Massa, Sean
    Mazul, Angela L.
    Kallogjeri, Dorina
    Yaeger, Lauren
    Jackson, Ryan S.
    Zevallos, Jose
    Pipkorn, Patrik
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2020, 41 (05)
  • [50] Mapping the research landscape of HPV-positive oropharyngeal cancer: a bibliometric analysis
    Mastroleo, Federico
    Ammirabile, Angela
    Giannitto, Caterina
    Alterio, Daniela
    Franzese, Ciro
    Scorsetti, Marta
    Franco, Pierfrancesco
    Marvaso, Giulia
    Jereczek, Barbara Alicja
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1338 - S1340